Preclinical biosafety studies of lentiviral vector-mediated gene therapy in erythrocyte pyruvate kinase deficiency

被引：0

作者：

Quintana-Bustamante, O. ^{[1
]}

Sanchez-Dominguez, R. ^{[1
]}

Garcia-Torralba, A. ^{[1
]}

Alberquilla, O. ^{[1
]}

Lopez-Manzaneda, S. ^{[1
]}

Fananas, S. ^{[1
]}

Nieto, V. ^{[1
]}

Molinos, A. ^{[1
]}

Garcia-Bravo, M. ^{[1
]}

Yanez, R. ^{[1
]}

Bueren, J. A. ^{[1
]}

Navarro, S. ^{[1
]}

Segovia, J. C. ^{[1
]}

机构：

[1] FJD, IIS, CIBERER, CIEMAT, Madrid, Spain

来源：

HUMAN GENE THERAPY | 2018年 / 29卷 / 12期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

P031

引用

页码：A39 / A39

页数：1

共 50 条

[21] Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Kaiser, Robert A.
Mao, Shennen A.
Glorioso, Jaime
Amiot, Bruce
Nicolas, Clara T.
Allen, Kari L.
Du, Zeji
VanLith, Caitlin J.
Hickey, Raymond D.
Nyberg, Scott L.
Lillegard, Joseph B.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (141):
[22] Improve transduction conditions of GMP-grade lentiviral vector for pyruvate kinase deficiency gene therapy clinical trial
Quintana-Bustamante, O.
Navarro, S.
Trigueros, C.
Villanueva, M.
Orman, I.
Bueren, J. A.
Ramirez, J. C.
Segovia, J. C.
HUMAN GENE THERAPY, 2017, 28 (12) : A21 - A21
[23] Lentiviral Vector-Mediated Stem Cell Gene Therapy for Mucopolysaccharidosis Type IIIA (MPSIIIA)
Langford-Smith, A. W. W.
Wilkinson, F. L.
Langford-Smith, K. J.
Bennett, W.
Howe, S.
Thrasher, A.
Hemsley, K.
Hopwood, J.
Wraith, J. E.
Wynn, R. F.
Bigger, B. W.
HUMAN GENE THERAPY, 2010, 21 (04) : 502 - 503
[24] Lentiviral Vector-Mediated Gene Transfer to Human Hair Follicles
Sriwiriyanont, Penkanok
Hachiya, Akira
Pickens, William L.
Moriwaki, Shigeru
Ohuchi, Atsushi
Kitahara, Takashi
Takema, Yoshinori
Kitzmiller, William J.
Visscher, Marty O.
Bello, Alexander
Tsuboi, Ryoji
Kobinger, Gary P.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (09) : 2296 - 2299
[25] Modulation of immune responses in lentiviral vector-mediated gene transfer
Annoni, Andrea
Gregori, Silvia
Naldini, Luigi
Cantore, Alessio
CELLULAR IMMUNOLOGY, 2019, 342
[26] Lentiviral vector-mediated gene transfer in bladder cancer cells
Matsunaga, Wataru
Ichikawa, Misa
Gotoh, Akinobu
CANCER SCIENCE, 2018, 109 : 1012 - 1012
[27] Interim Results from an Ongoing Global Phase 1 Study of Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency
Lopez Lorenzo, J. L.
Shah, A. J.
Sevilla, J.
Navarro, S.
Llanos, L.
de Camino Gaisse, B. Perez
Sanchez, S.
Zubicaray, J.
Glader, B.
Chien, M.
Bustamante, O.
Zeini, M.
Choi, G.
Nicoletti, E.
Rao, G. R.
Roncarolo, M. G.
Bueren, J. A.
Schwartz, J. D.
Segovia, J. C.
HUMAN GENE THERAPY, 2022, 33 (23-24) : A58 - A58
[28] Gene Therapy of Pyruvate Kinase Deficiency
Carlos Segovia, Jose
HUMAN GENE THERAPY, 2009, 20 (09) : 1033 - 1034
[29] Biosafety studies of a clinically-applicable lentiviral vector for gene therapy of RS-SCID
Charrier, S.
Moiani, A.
Lagresle, C.
Cedrone, G.
Sagrere, C.
Sanatine, P.
Gjata, B.
de Villartay, J. P.
Mavilio, F.
Cavazzana, M.
Hacein-Bey-Abina, S.
Galy, A.
HUMAN GENE THERAPY, 2013, 24 (12) : A109 - A109
[30] Efficient and Safe Lentiviral Vector-Mediated Hematopoietic Stem Cell Gene Therapy in MNGIE Mice
Yadak, Rana
Torronteras, Javier T.
Perez, Raquel C.
Bogaerts, Elly
de Ruijter, George
Barquinero, Jordi
Marti, Ramon
Smeets, Bert J.
Huston, Marshall W.
van Til, Niek P.
Wagemaker, Gerard
de Coo, Rene F. M.
MOLECULAR THERAPY, 2015, 23 : S111 - S112

← 1 2 3 4 5 →